Baupost Group - Q1 2018 holdings

$10.4 Billion is the total value of Baupost Group's 33 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 14.7% .

 Value Shares↓ Weighting
LNG  CHENIERE ENERGY INC$1,107,823,000
-0.7%
20,726,3400.0%10.68%
-3.2%
SYF  SYNCHRONY FINL$982,262,000
-13.2%
29,295,0300.0%9.47%
-15.3%
FOXA BuyTWENTY FIRST CENTY FOX INCcl a$975,541,000
+26.8%
26,588,731
+19.3%
9.41%
+23.6%
VSAT BuyVIASAT INC$897,613,000
-8.9%
13,658,137
+3.8%
8.66%
-11.1%
AGN BuyALLERGAN PLC$799,378,000
+8.6%
4,750,000
+5.6%
7.71%
+5.9%
QRVO  QORVO INC$774,950,000
+5.8%
11,000,0000.0%7.47%
+3.2%
TWX  TIME WARNER INC$766,098,000
+3.4%
8,100,0000.0%7.39%
+0.9%
PXD BuyPIONEER NAT RES CO$687,120,000
+98.8%
4,000,000
+100.0%
6.63%
+93.9%
AR BuyANTERO RES CORP$527,768,000
+12.4%
26,587,791
+7.5%
5.09%
+9.6%
FOX BuyTWENTY FIRST CENTY FOX INCcl b$415,831,000
+15.7%
11,433,358
+8.6%
4.01%
+12.9%
CAH  CARDINAL HEALTH INC$319,668,000
+2.3%
5,100,0000.0%3.08%
-0.2%
CLNS BuyCOLONY NORTHSTAR INC$279,243,000
-48.9%
49,687,370
+3.7%
2.69%
-50.2%
PBF SellPBF ENERGY INCcl a$268,630,000
-30.6%
7,924,175
-27.5%
2.59%
-32.3%
ATRA BuyATARA BIOTHERAPEUTICS INC$243,931,000
+151.5%
6,254,632
+16.7%
2.35%
+145.3%
MCK BuyMCKESSON CORP$227,604,000
+7.3%
1,615,700
+18.8%
2.20%
+4.7%
TBPH  THERAVANCE BIOPHARMA INC$225,747,000
-13.1%
9,309,1680.0%2.18%
-15.2%
VRTV BuyVERITIV CORP$149,916,000
+42.5%
3,824,385
+5.0%
1.45%
+38.9%
PCG NewPG&E CORP$138,378,0003,149,972
+100.0%
1.33%
ABC SellAMERISOURCEBERGEN CORP$113,557,000
-13.8%
1,317,216
-8.2%
1.10%
-15.9%
KERX  KERYX BIOPHARMACEUTICALS INC$105,488,000
-12.0%
25,791,6780.0%1.02%
-14.2%
AMC  AMC ENTMT HLDGS INC$70,250,000
-7.0%
5,000,0000.0%0.68%
-9.2%
NG BuyNOVAGOLD RES INC$58,313,000
+38.1%
13,467,145
+25.4%
0.56%
+34.8%
NewTESLA INCnote 2.375% 3/1$52,188,00050,000,000
+100.0%
0.50%
GTYHU  GTY TECHNOLOGY HOLDINGS INCunit 99/99/9999$45,540,000
+0.4%
4,400,0000.0%0.44%
-2.2%
PRTK  PARATEK PHARMACEUTICALS INC$31,128,000
-27.4%
2,394,4980.0%0.30%
-29.2%
 THERAVANCE BIOPHARMA INCnote 3.250%11/0$30,206,000
-8.6%
30,000,0000.0%0.29%
-11.0%
SCAC  SABAN CAP ACQUISITION CORP$23,125,000
+0.1%
2,326,5000.0%0.22%
-2.2%
STNLU  SENTINEL ENERGY SVCS INCunit 11/02/2022$15,872,000
-0.5%
1,600,0000.0%0.15%
-3.2%
IMOS SellCHIPMOS TECHNOLOGIES INCsponsored adr$14,798,000
-43.0%
933,658
-36.5%
0.14%
-44.4%
TMQ  TRILOGY METALS INC NEW$13,408,000
+16.6%
10,600,7580.0%0.13%
+13.2%
FWP SellFORWARD PHARMA A/Ssponsored adr$6,180,000
-59.8%
2,848,003
-31.9%
0.06%
-60.5%
SCACW  SABAN CAP ACQUISITION CORP*w exp 09/21/202$1,512,000
+4.9%
1,163,2500.0%0.02%
+7.1%
OREXQ  OREXIGEN THERAPEUTICS INC$465,000
-83.8%
2,226,8390.0%0.00%
-85.7%
RUN ExitSUNRUN INC$0-2,848,082
-100.0%
-0.17%
CASC ExitCASCADIAN THERAPEUTICS INC$0-8,721,079
-100.0%
-0.32%
ESRX ExitEXPRESS SCRIPTS HLDG CO$0-2,306,456
-100.0%
-1.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-05-14
Signatures

The EDGAR filing(s) were signed by:

About Baupost Group

Baupost Group is a Boston-based hedge fund founded by Seth Klarman in 1982. Klarman is a well-known value investor and author of the book "Margin of Safety". The firm has a reputation for being one of the most successful and secretive hedge funds in the world, with a focus on distressed debt, value investing, and event-driven strategies.

Baupost Group has a team of experienced investment professionals, including CEO and President James Mooney, COO Michael Apfel, and Chief Investment Officer Seth Klarman. The firm manages over $30 billion in assets and has a long-term investment horizon, often holding positions for several years.

The firm's investment philosophy is centered around the concept of margin of safety, which involves buying assets at a significant discount to their intrinsic value to minimize downside risk. Baupost Group is known for its disciplined approach to investing, conducting extensive research and analysis before making any investment decisions.

Baupost Group has a history of successful investments, including distressed debt investments in companies such as Enron and WorldCom. The firm also made a significant profit from its investment in the distressed debt of Lehman Brothers following the financial crisis.

Overall, Baupost Group is a highly respected hedge fund with a strong track record of successful investments. However, as with any investment, it is important for investors to conduct their own research and due diligence before making any investment decisions.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VIASAT INC42Q3 202320.0%
THERAVANCE BIOPHARMA INC38Q3 20234.2%
VERITIV CORP37Q3 202310.8%
ATARA BIOTHERAPEUTICS INC36Q3 20234.2%
TRILOGY METALS INC NEW29Q3 20230.4%
QORVO INC27Q3 20239.7%
CHENIERE ENERGY INC25Q1 202019.1%
THERAVANCE BIOPHARMA INC23Q2 20220.5%
NOVAGOLD RES INC22Q3 20181.9%
LIBERTY GLOBAL PLC21Q3 202316.6%

View Baupost Group's complete holdings history.

Latest significant ownerships (13-D/G)
Baupost Group Q1 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Garrett Motion Inc.August 10, 20235,987,2892.3%
Theravance Biopharma, Inc.July 10, 20237,419,22612.8%
Outbrain Inc.May 09, 20234,720,0008.4%
Archaea Energy Inc.Sold outFebruary 14, 202300.0%
Liberty Media CorpFebruary 14, 20237,677,6567.8%
Altimeter Growth Corp. 2Sold outFebruary 13, 202300.0%
Avanti Acquisition Corp.Sold outFebruary 13, 202300.0%
Liberty Media Acquisition CorpSold outFebruary 13, 202300.0%
Liberty Media CorpFebruary 13, 202313,651,0486.2%
VERINT SYSTEMS INCSold outFebruary 13, 202300.0%

View Baupost Group's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13
SC 13G2024-02-13
SC 13G/A2024-01-09
42023-12-06
SC 13D/A2023-12-04
13F-HR2023-11-13

View Baupost Group's complete filings history.

Compare quarters

Export Baupost Group's holdings